Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial (Q45543729)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 May 2011
edit
Language Label Description Also known as
English
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
scientific article published on 24 May 2011

    Statements

    Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial (English)
    B Walter
    I Schrettenbrunner
    M Vogelhuber
    J Grassinger
    T Suedhoff
    A Berand
    W F Wieland
    S Rogenhofer
    R Andreesen
    A Reichle
    24 May 2011
    799-805

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit